BCL2 and diabetic kidney disease: In contrast to the control group, the DKD group demonstrated a 2.7-fold increase in the expression of the proapoptotic gene (caspase-3) in the kidneys, and a 0.93-fold reduction in the antiapoptotic gene (Bcl-2) expression inside the kidneys (Fig. 5C and F).